Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CYP3A4-mediated effects of rifampicin on the pharmacokinetics of vilaprisan and its UGT1A1-mediated effects on bilirubin glucuronidation in humans.
Chattopadhyay N, Kanacher T, Casjens M, Frechen S, Ligges S, Zimmermann T, Rottmann A, Ploeger B, Höchel J, Schultze-Mosgau MH. Chattopadhyay N, et al. Among authors: zimmermann t. Br J Clin Pharmacol. 2018 Dec;84(12):2857-2866. doi: 10.1111/bcp.13750. Epub 2018 Oct 11. Br J Clin Pharmacol. 2018. PMID: 30171692 Free PMC article.
Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women.
Blode H, Zeun S, Parke S, Zimmermann T, Rohde B, Mellinger U, Kunz M. Blode H, et al. Among authors: zimmermann t. Contraception. 2012 Oct;86(4):337-44. doi: 10.1016/j.contraception.2012.01.010. Epub 2012 Mar 23. Contraception. 2012. PMID: 22445438 Clinical Trial.
The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial.
Joussen AM, Wolf S, Kaiser PK, Boyer D, Schmelter T, Sandbrink R, Zeitz O, Deeg G, Richter A, Zimmermann T, Hoechel J, Buetehorn U, Schmitt W, Stemper B, Boettger MK. Joussen AM, et al. Among authors: zimmermann t. Br J Clin Pharmacol. 2019 Feb;85(2):347-355. doi: 10.1111/bcp.13794. Epub 2018 Nov 25. Br J Clin Pharmacol. 2019. PMID: 30341774 Free PMC article. Clinical Trial.
Correction: Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Stahl A, Azuma N, Wu WC, Lepore D, Sukgen E, Nakanishi H, Mazela J, Leal S, Pieper A, Schlief S, Eissing T, Turner KC, Zhao A, Winkler J, Höchel J, Köfüncü E, Zimmermann T; FIREFLEYE Study Group. Stahl A, et al. Among authors: zimmermann t. Eye (Lond). 2024 Feb 8. doi: 10.1038/s41433-024-02948-y. Online ahead of print. Eye (Lond). 2024. PMID: 38332376 No abstract available.
881 results